Literature DB >> 20210782

Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV.

John H Elder1, Ying-Chuan Lin, Elizabeth Fink, Chris K Grant.   

Abstract

FIV is a significant pathogen in the cat and is, in addition, the smallest available natural model for the study of lentivirus infections. Although divergent at the amino acid level, the cat lentivirus has an abundance of structural and pathophysiological commonalities with HIV and thus serves well as a model for development of intervention strategies relevant to infection in both cats and man. The following review highlights both the strengths and shortcomings of the FIV/cat model, particular as regards development of antiviral drugs.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20210782      PMCID： PMC2853889          DOI： 10.2174/157016210790416389

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN： 1570-162X            Impact factor:   1.581


  116 in total

1.  Incorporation of uracil into viral DNA correlates with reduced replication of EIAV in macrophages.

Authors:  W K Steagall; M D Robek; S T Perry; F J Fuller; S L Payne
Journal:  Virology       Date:  1995-07-10       Impact factor: 3.616

2.  Analysis of a feline immunodeficiency virus provirus reveals patterns of gene sequence conservation distinct from human immunodeficiency virus type 1.

Authors:  D L Sodora; J Courcelle; J Brojatsch; A Berson; Y C Wang; S W Dow; E A Hoover; J I Mullins
Journal:  AIDS Res Hum Retroviruses       Date:  1995-04       Impact factor: 2.205

Review 3.  Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates.

Authors:  A G Tomasselli; R L Heinrikson
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

4.  Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus.

Authors:  A Wlodawer; A Gustchina; L Reshetnikova; J Lubkowski; A Zdanov; K Y Hui; E L Angleton; W G Farmerie; M M Goodenow; D Bhatt
Journal:  Nat Struct Biol       Date:  1995-06

5.  In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors.

Authors:  J H Condra; W A Schleif; O M Blahy; L J Gabryelski; D J Graham; J C Quintero; A Rhodes; H L Robbins; E Roth; M Shivaprakash
Journal:  Nature       Date:  1995-04-06       Impact factor: 49.962

6.  Differences in feline immunodeficiency virus host cell range correlate with envelope fusogenic properties.

Authors:  G Pancino; S Castelot; P Sonigo
Journal:  Virology       Date:  1995-02-01       Impact factor: 3.616

7.  Influence of ORF2 on host cell tropism of feline immunodeficiency virus.

Authors:  A K Waters; A P De Parseval; D L Lerner; J C Neil; F J Thompson; J H Elder
Journal:  Virology       Date:  1996-01-01       Impact factor: 3.616

8.  Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme.

Authors:  M Bouhamdan; S Benichou; F Rey; J M Navarro; I Agostini; B Spire; J Camonis; G Slupphaug; R Vigne; R Benarous; J Sire
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

9.  Early stages of feline immunodeficiency virus infection in lymph nodes and spleen.

Authors:  J M Bach; M Hurtrel; L Chakrabarti; J P Ganiere; L Montagnier; B Hurtrel
Journal:  AIDS Res Hum Retroviruses       Date:  1994-12       Impact factor: 2.205

10.  Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase.

Authors:  D L Lerner; P C Wagaman; T R Phillips; O Prospero-Garcia; S J Henriksen; H S Fox; F E Bloom; J H Elder
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205
View more
  59 in total

1.  Structural basis for drug and substrate specificity exhibited by FIV encoding a chimeric FIV/HIV protease.

Authors:  Ying Chuan Lin; Alexander L Perryman; Arthur J Olson; Bruce E Torbett; John H Elder; C David Stout
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-05-12

2.  Feline Immunodeficiency Virus Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.

Authors:  Qinyong Gu; Zeli Zhang; Lucía Cano Ortiz; Ana Cláudia Franco; Dieter Häussinger; Carsten Münk
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

3.  Treatment of chronically FIV-infected cats with suberoylanilide hydroxamic acid.

Authors:  Samantha J McDonnel; Molly L Liepnieks; Brian G Murphy
Journal:  Antiviral Res       Date:  2014-06-02       Impact factor: 5.970

4.  Accessory genes confer a high replication rate to virulent feline immunodeficiency virus.

Authors:  Ryan M Troyer; Jesse Thompson; John H Elder; Sue VandeWoude
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

Review 5.  Retroviral restriction and dependency factors in primates and carnivores.

Authors:  Hind J Fadel; Eric M Poeschla
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

6.  Conserved epitopes on HIV-1, FIV and SIV p24 proteins are recognized by HIV-1 infected subjects.

Authors:  Shannon R Roff; Missa P Sanou; Mobeen H Rathore; Jay A Levy; Janet K Yamamoto
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

7.  FIV diversity: FIV Ple subtype composition may influence disease outcome in African lions.

Authors:  Jennifer L Troyer; Melody E Roelke; Jillian M Jespersen; Natalie Baggett; Valerie Buckley-Beason; Dan MacNulty; Meggan Craft; Craig Packer; Jill Pecon-Slattery; Stephen J O'Brien
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

8.  Structural and Mechanistic Studies of the Rare Myristoylation Signal of the Feline Immunodeficiency Virus.

Authors:  Janae B Brown; Holly R Summers; Lola A Brown; Jan Marchant; Paige N Canova; Colin T O'Hern; Sophia T Abbott; Constance Nyaunu; Simon Maxwell; Talayah Johnson; Morgan B Moser; Sherimay D Ablan; Hannah Carter; Eric O Freed; Michael F Summers
Journal:  J Mol Biol       Date:  2020-05-19       Impact factor: 5.469

9.  Fine definition of the CXCR4-binding region on the V3 loop of feline immunodeficiency virus surface glycoprotein.

Authors:  Qiong-Ying Hu; Elizabeth Fink; Yang Hong; Cathy Wang; Chris K Grant; John H Elder
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

10.  Feline models of viral pathogenesis: opportunity knocks.

Authors:  Jennifer L Troyer; Meredith A Brown
Journal:  Vet J       Date:  2010-08-15       Impact factor: 2.688
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.